← Back to Search

Procedure

Installation of Study Sentinal Node Dye for Endometrial Cancer (SITs Trial)

N/A
Waitlist Available
Led By Giuseppe Del Priore, MD
Research Sponsored by Southeastern Regional Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

SITs Trial Summary

The purpose of this study is to compare the Instillation Technique Using The Modified Intra- Uterine Manipulator Catheter With Methylene Blue, Isosulfan Blue or Indocyanine Green Dyes, Compared to Cervical Injection, For Sentinel Lymph Node Detection in Endometrial Carcinoma.

Eligible Conditions
  • Endometrial Cancer

SITs Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of sentinel nodes detected by each method.
Secondary outcome measures
Sensitivity of each method compared to full node dissection.
Time to detection of 1st SN by each method.

SITs Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Installation of Study Sentinal Node DyeExperimental Treatment1 Intervention
Surgery route, as determined by the patient and clinician, will determine which study dye will be used for delivery by the experimental route.
Group II: Standard of Care Sentinal Node DyeActive Control1 Intervention
Surgery route, as determined by the patient and clinician, will determine which standard clinical dye will be used.

Find a Location

Who is running the clinical trial?

Southeastern Regional Medical CenterLead Sponsor
1 Previous Clinical Trials
50 Total Patients Enrolled
Giuseppe Del Priore, MDPrincipal InvestigatorSoutheastern Regional Medical Center
3 Previous Clinical Trials
219 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby May 2025